Biohit Oyj, Other information disclosed according to the rules of the Exchange,
June 29, 2021 at 9:30 am local time (EEST)
Biohit Oyj’s Board of Directors has in its meeting yesterday (28 June) elected
Commercial Counsellor Eero Lehti as the Chairman of the Board of Directors.
Additional information:
Deputy CEO Osmo Suovaniemi, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission
is “Innovating for Health” – we produce innovative products and services to
promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV)
is quoted on Nasdaq Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=ciyb_
iZ945H2z3sK3a9i7Zs03Nkj9jr5Brw7kC1tsoUye5PVgko06PC57Z9BVVT2pXUgp6sn
-tswLd2MUgQOQc8UNXD2BkNm3L02XzRJ7XfJCPaPUqGS1mpI0NZinK5T)